Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Antioxidant properties linked to copper chelation and modulation of cellular oxidative stress
A phase II study of the HDAC inhibitor givinostat in combination with hydroxyurea in patients with polycythemia vera resistant to hydroxyurea monotherapy
About five minutes total, including intake
For most patients, the first dose is administered in the week preceding further therapy, with follow-ups every few weeks to help alleviate symptoms and support better health outcomes
US$ 21.71
US$ 25.20
US$ 24.58
US$ 24.11
US$ 23.56
